FDA approval to targeted imaging agent pafolacianine for use in lung cancer surgery Isra Zaman20 Dec 2022 10:00 AM ISTMore than 130,000 Americans die of lung cancer each year, making lung cancer the leading cause of cancer mortality in the country. Lung cancer...
FDA approves "glowing tumor" imaging agent Cytalux to aid lung cancer surgery Dr. Kamal Kant Kohli20 Dec 2022 9:00 AM ISTThe U.S. Food and Drug Administration (FDA) has approved the targeted imaging agent Cytalux (pafolacianine) for use in lung cancer surgery. This...
Biologics may lower risk of advanced-stage IBD-associated intestinal cancer Niveditha Subramani19 Dec 2022 6:00 AM ISTA recent nationwide study in The American Journal of Gastroenterology by Dr Ryo Seishima, M.D., Ph.D and team reports that biologic use linked with...
Explanation to why immunotherapies don't work on hardest-to-treat breast cancers Isra Zaman17 Dec 2022 9:45 AM ISTThe process of surviving chemotherapy triggers a program of immune checkpoints that shield breast cancer cells from different lines of attack by the...
Perioperative use of Propranolol and etodolac markedly reduces metastases risk after colon cancer surgery Dr. Kamal Kant Kohli15 Dec 2022 9:45 AM ISTResearchers at Tel Aviv University have found in a new study that Propranolol used to lower blood pressure and reduce anxiety and etodolac used...
Exercise, even in late stages of the disease suppresses growth of cancer cells Isra Zaman15 Dec 2022 9:30 AM ISTPrevious work from ECU's Exercise Medicine Research Institute has shown men with advanced prostate cancer can change the chemical environment of...
Late-breaking research results for acute lymphoblastic leukemia (ALL) Isra Zaman14 Dec 2022 9:15 AM ISTAcute lymphocytic leukemia (ALL) is a kind of blood and bone marrow malignancy. Blood cells are generated in the spongy tissue inside the bones....
Modakafusp alfa shows promise in treating multiple myeloma, study finds Isra Zaman13 Dec 2022 9:00 AM ISTAccording to the American Cancer Society, about 12,640 deaths from multiple myeloma are expected to occur in the U.S. in 2022. The cancer is...
Novel drug shows early promise in treating multiple myeloma Dr. Kamal Kant Kohli12 Dec 2022 8:00 PM IST A first-of-its-kind drug known as modakafusp alfa has shown early potential in combating multiple myeloma, a form of bone marrow cancer, in a...
73 percent of patients in two clinical trials exhibit success in experimental cancer therapy Isra Zaman12 Dec 2022 9:45 AM ISTNearly all patients with myeloma who receive standard therapies continually relapse. Patients who relapse or become resistant to all approved...
Three-drug combination therapy effective in patients with high-risk CLL, trial shows Dr. Kamal Kant Kohli12 Dec 2022 6:00 AM ISTResearchers have found in a phase 2 clinical trial led by Dana-Farber Cancer Institute that three-drug combination that sent chronic lymphocytic...
Adjuvant chemotherapy improves overall survival for pancreatic cancer patients: JAMA Oncology study Isra Zaman10 Dec 2022 9:30 AM ISTCancer that develops in pancreatic cells is known as pancreatic cancer. The pancreas is an organ in your abdomen that is located behind the bottom...
